The molecular mechanism of EGF receptor activation in pancreatic β-cells by thyrotropin-releasing hormone

American Journal of Physiology - Endocrinology and Metabolism

Volumn 290, Issue 5, 2006, Pages

  Luo, LuGuang ^a   Yano, Naohiro ^b   Luo, John Z Q ^c  

^a ROGER WILLIAMS MEDICAL CENTER   (United States)

^b Pediatrics Women and Infants Hospital

^c BROWN UNIVERSITY   (United States)

Author keywords

G protein; Heparin binding epidermal growth factor like growth factor; Protein kinase C; Signal transduction; Src

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; PROTIRELIN; PROTIRELIN DERIVATIVE; STROMELYSIN; THYROTROPHIN RELEASING HORMONE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ENZYME ACTIVATION; GENE EXPRESSION; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES; BASE SEQUENCE; CELL LINE; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION; GTP-BINDING PROTEIN BETA SUBUNITS; INSULIN-SECRETING CELLS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN KINASE C; PYRIMIDINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, THYROTROPIN-RELEASING HORMONE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; THYROTROPIN-RELEASING HORMONE; TYROSINE;

EID: 33646389798     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00466.2005     Document Type: Article

References (42)

1. Alhan E, Kucuktulu U, Ercin C, Efe H, and Al S. The effects of calcium channel blocker and thyrotropin releasing hormone on acute necrotizing pancreatitis in rats. Res Exp Med (Berl) 199: 51-58, 1999.
2. Andreev J, Galisteo ML, Kranenburg O, Logan SK, Chiu ES, Okigaki M, Cary LA, Moolenaar WH, and Schlessinger J. Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade. J Biol Chem 276: 20130-20135, 2001.
3. Arnush M, Gu D, Baugh C, Sawyer SP, Mroczkowski B, Krahl T, and Sarvetnick N. Growth factors in the regenerating pancreas of gamma-interferon transgenic mice. Lab Invest 74: 985-990, 1996.
4. Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, Ohmoto H, Node K, Yoshino K, Ishiguro H, Asanuma H, Sanada S, Matsumura Y, Takeda H, Beppu S, Tada M, Hori M, and Higashiyama S. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med 8: 35-40, 2002.
5. Basmaciogullari A, Cras-Meneur C, Czernichow P, and Scharfmann R. Pancreatic pattern of expression of thyrotropin-releasing hormone during rat embryonic development. J Endocrinol 166: 481-488, 2000.
6. Buteau J, Foisy S, Rhodes CJ, Carpenter L, Biden TJ, and Prentki M. Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation. Diabetes 50: 2237-2243, 2001.
7. Chen X, Tang S, and Tashjian AH Jr. Novel action of pituitary adenylate cyclase-activating polypeptide. Stimulation of extracellular acidification in rat pituitary GH4C1 cells. Cell Signal 12: 255-263, 2000.
8. Chiu T, Wu SS, Santiskulvong C, Tangkijvanich P, Yee HF Jr, and Rozengurt E. Vasopressin-mediated mitogenic signaling in intestinal epithelial cells. Am J Physiol Cell Physiol 282: C434-C450, 2002.
9. Cras-Meneur C, Elghazi L, Czernichow P, and Scharfmann R. Epidermal growth factor increases undifferentiated pancreatic embryonic cells in vitro: a balance between proliferation and differentiation. Diabetes 50: 1571-1579, 2001.
10. Daub H, Wallasch C, Lankenau A, Herrlich A, and Ullrich A. Signal characteristics of G protein-transactivated EGF receptor. EMBO J 16: 7032-7044, 1997.
11. Dikic I, Tokiwa G, Lev S, Courtneidge SA, and Schlessinger J. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383: 547-550, 1996.
12. Emanuel RL, Torday JS, Asokananthan N, and Sunday ME. Direct effects of corticotropin-releasing hormone and thyrotropin-releasing hormone on fetal lung explants. Peptides 21: 1819-1829, 2000.
13. Filardo EJ, Quinn JA, Bland KI, and Frackelton AR Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14: 1649-1660, 2000.
14. Gordeladze JO, Rur H, Attramadal A, Tveter K, Gautvik KM, and Purvis K. Distribution of Thyroliberin (TRH)- and 12-O-tetradecanoylphorbol 13-acetate (TPA)-activated adenylyl cyclase in normal and neoplastic tissue with special reference to the prostate. Mol Cell Endocrinol 58: 287-290, 1988.
15. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, and Connelly PA. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem 271: 695-701, 1996.
16. Kalmes A, Daum G, and Clowes AW. EGFR transactivation in the regulation of SMC function. Ann NY Acad Sci 947: 42-54, 2001.
17. Kaneto H, Xu G, Fujii N, Kim S, Bonner-Weir S, and Weir GC. Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. J Biol Chem 277: 30010-30018, 2002.
18. Kelly JA, Slator GR, and O'Boyle KM. Pharmacologically distinct binding sites in rat brain for [3H]thyrotropin-releasing hormone (TRH) and [3H][3-methyl-histidine(2)]TRH. Biochem Pharmacol 63: 2197-2206, 2002.
19. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, and McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292: 1389-1394, 2001.
20. Luo LG and Jackson IM. Glucocorticoids stimulate TRH and c-fos/c-jun gene co-expression in cultured hypothalamic neurons. Brain Res 791: 56-62, 1998.
21. Luo LG and Yano N. Expression of thyrotropin-releasing hormone receptor in immortalized beta-cell lines and rat pancreas. J Endocrinol 181: 401-412, 2004.
22. Martino E, Lernmark A, Seo H, Steiner DF, and Refetoff S. High concentration of thyrotropin-releasing hormone in pancreatic islets. Proc Natl Acad Sci USA 75: 4265-4267, 1978.
23. Mathis D, Vence L, and Benoist C. beta-Cell death during progression to diabetes. Nature 414: 792-798, 2001.
24. Naglich JG, Metherall JE, Russell DW, and Eidels L. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 69: 1051-1061, 1992.
25. Ohmichi M, Sawada T, Kanda Y, Koike K, Hirota K, Miyake A, and Saltiel AR. Thyrotropin-releasing hormone stimulates MAP kinase activity in GH3 cells by divergent pathways. Evidence of a role for early tyrosine phosphorylation. J Biol Chem 269: 3783-3788, 1994.
26. Palomero T, Barros F, del Camino D, Viloria CG, and de la Pena P. A G protein beta gamma dimer-mediated pathway contributes to mitogen-activated protein kinase activation by thyrotropin-releasing hormone receptors in transfected COS-7 cells. Mol Pharmacol 53: 613-622, 1998.
27. Pickett CA, Manning N, Akita Y, and Gutierrez-Hartmann A. Role of specific protein kinase C isozymes in mediating epidermal growth factor, thyrotropin-releasing hormone, and phorbol ester regulation of the rat prolactin promoter in GH4/GH4C1 pituitary cells. Mol Endocrinol 16: 2840-2852, 2002.
28. Pierce KL, Tohgo A, Ahn S, Field ME, Luttrell LM, and Lefkowitz RJ. Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors: a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding. J Biol Chem 276: 23155-23160, 2001.
29. Pizzi M, Boroni F, Benarese M, Moraitis C, Memo M, and Spano P. Neuroprotective effect of thyrotropin-releasing hormone against excitatory amino acid-induced cell death in hippocampal slices. Eur J Pharmacol 370: 133-137, 1999.
30. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, and Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402: 884-888, 1999.
31. Sato K, Sato A, Aoto M, and Fukami Y. c-Src phosphorylates epidermal growth factor receptor on tyrosine 845. Biochem Biophys Res Commun 215: 1078-1087, 1995.
32. Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, and Kondo H. New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids. J Med Chem 45: 919-929, 2002.
33. Smith FE, Rosen KM, Villa-Komaroff L, Weir GC, and Bonner-Weir S. Enhanced insulin-like growth factor I gene expression in regenerating rat pancreas. Proc Natl Acad Sci USA 88: 6152-6156, 1991.
34. Smith J, Yu R, and Hinkle PM. Activation of MAPK by TRH requires clathrin-dependent endocytosis and PKC but not receptor interaction with beta-arrestin or receptor endocytosis. Mol Endocrinol 15: 1539-1548, 2001.
35. Suzuki M, Raab G, Moses MA, Fernandez CA, and Klagsbrun M. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J Biol Chem 272: 31730-31737, 1997.
36. Thomson AM, Rogers JT, and Leedman PJ. Thyrotropin-releasing hormone and epidermal growth factor regulate iron-regulatory protein binding in pituitary cells via protein kinase C-dependent and -independent signaling pathways. J Biol Chem 275: 31609-31615, 2000.
37. Wang YH, Jue SF, and Maurer RA. Thyrotropin-releasing hormone stimulates phosphorylation of the epidermal growth factor receptor in GH3 pituitary cells. Mol Endocrinol 14: 1328-1337, 2000.
38. Wolff G, Mastrangeli A, Heinflink M, Falck-Pedersen E, Gershengorn MC, and Crystal RG. Ectopic expression of thyrotropin releasing hormone (TRH) receptors in liver modulates organ function to regulate blood glucose by TRH. Nat Genet 12: 274-279, 1996.
39. Yamada M, Saga Y, Shibusawa N, Hirato J, Murakami M, Iwasaki T, Hashimoto K, Satoh T, Wakabayashi K, Taketo MM, and Mori M. Tertiary hypothyroidism and hyperglycemia in mice with targeted disruption of the thyrotropin-releasing hormone gene. Proc Natl Acad Sci USA 94: 10862-10867, 1997.
40. Yamada M, Shibusawa N, Hashida T, Ozawa A, Monden T, Satoh T, and Mori M. Expression of thyrotropin-releasing hormone (TRH) receptor subtype 1 in mouse pancreatic islets and HIT-T15, an insulin-secreting clonal beta cell line. Life Sci 66: 1119-1125, 2000.
41. Yano N, Asakura K, Endoh M, Abe Y, Nomoto Y, Sakai H, Kurokawa K, and Tsukamoto H. Polymorphism in the Ialpha1 germ-line transcript regulatory region and IgA productivity in patients with IgA nephropathy. J Immunol 160: 4936-4942, 1998.
42. Yano N, Endoh M, Nomoto Y, Sakai H, Fadden K, and Rifai A. Phenotypic characterization of cytokine expression in patients with IgA nephropathy. J Clin Immunol 17: 396-403, 1997.